TBKG Osimertinib ADR Case Study Data
Clinical validation dataset with calculated ADRs for osimertinib ranked by importance, biomarker pathways explaining drug-ADR relationships, and clinical data from 8 lung adenocarcinoma patients. Model achieved Kappa=0.68 concordance with official manual and 0.81 three-fold cross-validation accuracy.